Shareholders' Equity (Deficit) (Details) - Schedule of stock warrants - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Shareholders' Equity (Deficit) (Details) - Schedule of stock warrants [Line Items]
Outstanding at beginning of the period	47,056,293	46,161,463
Weighted Average Exercise Price, Outstanding at beginning of the period	$ 0.17	$ 0.18
Granted during the period	3,582,873	5,864,843
Weighted Average Exercise Price, Granted during the period	$ 0.20	$ 0.22
Contractual adjustments to number of warrant shares during the period	1,949,535
Weighted Average Exercise Price, Contractual adjustments to number of warrant shares during the period	$ 0.08
Exercised during the period	(1,185,715)	(4,970,013)
Weighted Average Exercise Price, Exercised during the period	$ (0.07)	$ 0.00
Expired during the period	(50,000)
Weighted Average Exercise Price, Expired during the period	$ 0.40
Outstanding at end of the period	51,352,986	47,056,293
Weighted Average Exercise Price, Outstanding at end of the period	$ 0.17	$ 0.21
Exercisable at end of the period	51,352,986	47,056,293
Weighted Average Exercise Price, Exercisable at end of the period	$ 0.17	$ 0.21
Weighted average remaining life	3 years 36 days	3 years
Weighted average remaining life